查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1726346

全球自扩增 RNA 合成市场：市场规模、份额、趋势分析（按产品/服务、应用、最终用途和地区）、细分市场预测（2025-2030 年）

Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report By Product & Service, By Application By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

自扩增 RNA 合成市场的成长与趋势：

预计到 2030 年，全球自扩增 RNA 合成市场规模将达到 3.108 亿美元，2025 年至 2030 年的复合年增长率为 19.24%。

这种扩张主要是由于对基于 RNA 的疫苗和疗法的需求不断增长，尤其是在 COVID-19 大流行期间。由于其能够诱导更强的免疫反应，研究人员正在将 saRNA 视为快速开发疫苗的有希望的平台。 RNA 的自我扩增能力允许使用较低剂量，可能产生较少的副作用，因此在临床试验中获得支持。因此，製药公司正专注于将 saRNA 纳入其产品平臺，进一步推动市场成长。

人们对个人化医疗的兴趣日益浓厚也是推动市场扩张的关键因素。随着基因组技术的进步，针对特定基因特征的个人化治疗的需求日益增长。自扩增 RNA 技术使得开发针对个别患者的疫苗和基因疗法成为可能。此外，随着医疗保健系统转向更个人化的治疗，对 saRNA 等创新解决方案的需求将持续成长。

此外，全球感染疾病的增加和对新治疗方案的迫切需求为 saRNA 技术创造了有利的环境。除了疫苗之外，自扩增 RNA 也被用于治疗多种疾病，包括癌症、遗传疾病和自体免疫疾病。 saRNA 可用于多种应用，提供广泛的治疗选择，并吸引公共和私营部门的大量投资。此外，RNA 技术的不断进步和临床试验的增加预计将加速市场采用。人们对此类多疾病应用的兴趣日益浓厚，确保了未来几年全球自扩增 RNA 合成市场的光明前景。

自扩增 RNA 合成市场：分析概述

  • 根据产品/服务提供，客製化合成服务部门预计将在预测期内见证最快的成长率，这归因于对客製化 RNA 解决方案的需求不断增加，这对于个人化药物和基于 RNA 的治疗方法的开发至关重要。
  • 根据应用，治疗药物开发领域预计将占据市场主导地位，收益占有率。
  • 根据最终用途，製药和生物技术公司部门在 2024 年占据了最大的收益占有率。这些公司负责 RNA 疗法研究、产品开发和大规模製造，对 RNA 合成服务产生了巨大的需求。他们的大量投资，尤其是在疫苗製造和基因治疗的 RNA 技术方面的投资，使他们成为市场的主要参与者。随着越来越多的基于 RNA 的治疗方法（包括新型疫苗和基因疗法）投入开发，这些公司继续成为 RNA 合成解决方案的主要最终用户。
  • 按地区划分，北美在 2024 年占据自扩增 RNA 合成市场的最大收入份额。美国继续引领 RNA 技术研究，并在基于 RNA 的疗法和疫苗的开发方面投入大量资金。

目录

第一章 分析方法与范围

第二章执行摘要

3. 自扩增 RNA 合成市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 自扩增 RNA 合成市场：分析工具
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 自扩增 RNA 合成市场：按产品和服务进行的估计和趋势分析

  • 产品/服务仪表板
  • 全球自扩增 RNA 合成市场（依产品与服务）的波动
  • 全球自扩增 RNA 合成市场：按产品和服务分類的市场规模和趋势分析（2018-2030 年）
  • 产品
    • 产品：市场规模预测与趋势分析（2018-2030年）
    • 预製saRNA
    • 酵素和试剂
    • 其他的
  • 客製化合成服务
    • 客製化合成服务：市场规模预测与趋势分析（2018-2030）

第五章 自扩增 RNA 合成市场：按应用进行的估计和趋势分析

  • 特定于应用程式的仪表板
  • 全球自扩增RNA合成市场波动分析（依应用）
  • 全球自扩增 RNA 合成市场：市场规模与趋势分析（按应用划分）（2018-2030 年）
  • 药物开发
    • 治疗药物开发：市场规模预测与趋势分析（2018-2030）
    • 感染疾病
    • 瘤
    • 其他的
  • 生物医学研究
    • 生物医学研究：市场规模预测与趋势分析（2018-2030）

第六章 自扩增 RNA 合成市场：依最终用途的估计与趋势分析

  • 最终用途仪表板
  • 全球自扩增 RNA 合成市场趋势分析（依最终用途）
  • 全球自扩增 RNA 合成市场：依最终用途分類的市场规模与趋势分析（2018-2030 年）
  • 製药和生物技术公司
    • 製药和生物技术公司：市场规模预测和趋势分析（2018-2030）
  • 学术研究所
    • 学术研究机构：市场规模预测与趋势分析（2018-2030）
  • 其他最终用途
    • 其他最终用途：市场规模预测与趋势分析（2018-2030）

第七章 自扩增 RNA 合成市场：按地区估计和趋势分析

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 区域市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与企业
  • 企业市场分析（2024年）
  • 战略地图
  • 参与企业概况
    • 金斯瑞
    • 创新百健
    • OZ 生物科学
    • 中银科学
    • 科洛伊斯生物科学有限公司
    • 创新生物实验室
    • 马拉威生命科学
    • Areterna有限责任公司
    • 应用DNA科学（LineaRx）
Product Code: GVR-4-68040-557-8

Self-amplifying RNA Synthesis Market Growth & Trends:

The global self-amplifying RNA synthesis market size is expected to reach USD 310.8 million by 2030 and is anticipated to grow at a CAGR of 19.24% from 2025 to 2030. This expansion is largely driven by the increasing demand for RNA-based vaccines and therapies, particularly during the COVID-19 pandemic. Researchers are turning to saRNA as a promising platform for rapid vaccine development due to its ability to induce a stronger immune response. The self-amplification feature of RNA allows for lower dosages and potentially fewer side effects, which is gaining traction in clinical trials. As a result, pharmaceutical companies are focusing on incorporating saRNA into their product pipelines, further boosting market growth.

The growing interest in personalized medicine is another key factor contributing to the market's expansion. With advancements in genomic technologies, there is an increasing need for tailored treatments targeting specific genetic profiles. Self-amplifying RNA technologies enable the development of vaccines and gene therapies that can be customized for individual patients. Furthermore, as healthcare systems shift toward more personalized care, the demand for innovative solutions such as saRNA will continue to rise.

In addition, the global rise in infectious diseases and the urgent need for new therapeutic options create a favorable environment for saRNA technologies. Beyond vaccines, self-amplifying RNA is being explored for various diseases, including cancer, genetic disorders, and autoimmune diseases. The ability of saRNA to be engineered for different applications allows for diverse therapeutic options, attracting substantial investment from the public and private sectors. Moreover, the ongoing advancements in RNA technology and the increasing number of clinical trials are expected to accelerate market adoption. This growing interest in multi-disease applications ensures a promising outlook for the global self-amplifying RNA synthesis market in the coming years.

Self-amplifying RNA Synthesis Market Report Highlights:

  • Based on product & service, the custom synthesis services segment is expected to witness the fastest growth rate during the forecast period, due to the increasing demand for tailored RNA solutions, which are essential in the development of personalized medicines and RNA-based therapeutics.
  • Based on an application, the therapeutics development segment dominated the market and accounted for the largest revenue share in 2024, driven by the surge in research and development of RNA-based therapeutics, such as vaccines and gene-editing tools, which have significantly contributed to the growth of this segment.
  • Based on end use, the pharmaceutical & biotechnology companies segment held the largest revenue share in 2024. These companies are in charge of RNA therapeutic research, product development, and large-scale production, thus creating a substantial demand for RNA synthesis services. Their significant investments in RNA technology, particularly for vaccine production and genetic therapies, have positioned them as major players in the market. The growing number of RNA-based therapies in development, including novel vaccines and gene therapies, ensures that these companies remain the primary end-users of RNA synthesis solutions.
  • Based on region, North America held the largest revenue share in 2024 in the self-amplifying RNA synthesis market, primarily driven by the region's strong pharmaceutical and biotechnology industries. The U.S. continues to lead RNA technology research, with significant investments in RNA-based therapeutics and vaccine development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Self-Amplifying RNA Synthesis Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in RNA Technology
      • 3.2.1.2. Rising Demand for Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Manufacturing and Scalability Challenges
      • 3.2.2.2. Regulatory and Scientific Hurdles
  • 3.3. Self-Amplifying RNA Synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Self-Amplifying RNA Synthesis Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Self-Amplifying RNA Synthesis Market Product & Service Movement Analysis
  • 4.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.2. Premade saRNA
      • 4.4.2.1. Premade saRNA Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3. Enzymes & Reagents
      • 4.4.3.1. Enzymes & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Custom Synthesis Services
    • 4.5.1. Custom Synthesis Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Self-Amplifying RNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Self-Amplifying RNA Synthesis Market Application Movement Analysis
  • 5.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Therapeutics Development
    • 5.4.1. Therapeutics Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.2. Infectious Diseases
      • 5.4.2.1. Infectious Diseases Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Oncology Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Biomedical Research
    • 5.5.1. Biomedical Research Techniques Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Self-Amplifying RNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Self-Amplifying RNA Synthesis Market End Use Movement Analysis
  • 6.3. Global Self-Amplifying RNA Synthesis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.6. Other End Use
    • 6.6.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. Self-Amplifying RNA Synthesis Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Strategy Mapping
  • 8.4. Participants Overview
    • 8.4.1. GenScript
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product & Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Creative Biogene
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product & Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. OZ Biosciences
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product & Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BOC Sciences
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product & Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Croyez Bioscience Co., Ltd.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product & Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Creative Biolabs
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product & Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Maravai LifeSciences
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product & Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Areterna LLC
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product & Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Applied DNA Sciences, Inc. (LineaRx)
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product & Service benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 3 North America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 4 North America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 North America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 7 U.S. Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 10 Canada Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 Canada Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 20 UK Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 UK Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Germany Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Italy Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 France Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 29 France Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Spain Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 35 Sweden Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 38 Denmark Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 41 Norway Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 42 Norway Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 China Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 China Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 51 Japan Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 India Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 54 India Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 India Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 57 South Korea Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Australia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Australia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Australia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 66 Latin America Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Latin America Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 70 Brazil Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Argentina Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Middle East Africa Self-Amplifying RNA Synthesis Market, by Country, 2018 - 2030 (USD Million)
  • Table 76 Middle East Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 Middle East Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Middle East Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 80 South Africa Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 86 UAE Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 UAE Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Self-Amplifying RNA Synthesis Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Self-Amplifying RNA Synthesis Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Self-Amplifying RNA Synthesis Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling for Market Share Assessment
  • Fig. 7 Market formulation & Validation
  • Fig. 8 Self-Amplifying RNA Synthesis Market: Market Outlook
  • Fig. 9 Parent Market Outlook
  • Fig. 10 Related/Ancillary Market Outlook
  • Fig. 11 Penetration and Growth Prospect Mapping
  • Fig. 12 Industry Value Chain Analysis
  • Fig. 13 Self-Amplifying RNA Synthesis Market Driver Impact
  • Fig. 14 Self-Amplifying RNA Synthesis Market Restraint Impact
  • Fig. 15 Self-Amplifying RNA Synthesis Market Strategic Initiatives Analysis
  • Fig. 16 Self-Amplifying RNA Synthesis Market: Product & Service Movement Analysis
  • Fig. 17 Self-Amplifying RNA Synthesis Market: Product & Service Outlook and Key Takeaways
  • Fig. 18 Products Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Premade saRNA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Custom Synthesis Services Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Self-Amplifying RNA Synthesis Market: Application Movement Analysis
  • Fig. 24 Self-Amplifying RNA Synthesis Market: Application Outlook and Key Takeaways
  • Fig. 25 Therapeutics Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Biomedical Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Self-Amplifying RNA Synthesis Market: End-Use Movement Analysis
  • Fig. 31 Self-Amplifying RNA Synthesis Market: End-Use Outlook and Key Takeaways
  • Fig. 32 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Other End Use Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global Self-Amplifying RNA Synthesis Market: Regional Movement Analysis
  • Fig. 36 Global Self-Amplifying RNA Synthesis Market: Regional Outlook and Key Takeaways
  • Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Country Dynamics
  • Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Country Dynamics
  • Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Country Dynamics
  • Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK Country Dynamics
  • Fig. 46 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Country Dynamics
  • Fig. 48 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Country Dynamics
  • Fig. 50 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Country Dynamics
  • Fig. 52 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Country Dynamics
  • Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Country Dynamics
  • Fig. 56 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden Country Dynamics
  • Fig. 58 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway Country Dynamics
  • Fig. 60 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 China Country Dynamics
  • Fig. 63 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan Country Dynamics
  • Fig. 65 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India Country Dynamics
  • Fig. 67 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand Country Dynamics
  • Fig. 69 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea Country Dynamics
  • Fig. 71 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Country Dynamics
  • Fig. 73 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil Country Dynamics
  • Fig. 76 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina Country Dynamics
  • Fig. 78 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa Country Dynamics
  • Fig. 81 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia Country Dynamics
  • Fig. 83 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 UAE Country Dynamics
  • Fig. 85 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait Country Dynamics
  • Fig. 87 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market Position of Key Market Players